People prescribed GLP-1 agents liraglutide (Saxenda) or semaglutide for weight loss decreased their alcohol intake by almost ...

Many are from the most deprived areas, and a significant number are neurodivergent or have other health conditions, a study ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

The NHS has been urged to accelerate the rollout of weight loss drugs to "many millions" of people, as experts hailed the ...

I worry about how these changes, which are occurring at the age of 13 or 14, might affect them later in life,” the study’s lead author said.

Volume 17, Issue 4, on April 7, 2025, titled "Pharmacological recapitulation of the lean phenotype induced by the ...

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

Today, the Obesity Association™, a division of the American Diabetes Association®, (Obesity Association) announced the ...

Adolescents with abdominal obesity have larger brain regions linked to memory and emotional control, potentially due to ...